Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

September 1, 2021; Volume 62,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Afshar-Oromieh, Ali

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  2. Al-Toubah, Taymeyah

    1. You have access
      Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Jonathan R. Strosberg, Taymeyah Al-Toubah and Ghassan El-Haddad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1321; DOI: https://doi.org/10.2967/jnumed.121.262340
  3. Alagille, David

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  4. Alano, Rejah

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  5. Alberts, Ian

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  6. Allen, Isabel E.

    1. Assessment and Comparison of <sup>18</sup>F-Fluorocholine PET and <sup>99m</sup>Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      You have access
      Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh and Thomas A. Hope
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1285-1291; DOI: https://doi.org/10.2967/jnumed.120.257303
  7. Allen-Auerbach, Martin

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  8. Ansquer, Catherine

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  9. Antonarakis, Emmanuel S.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  10. Armstrong, Wesley R.

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  11. Aulehner, Christina

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  12. Azargoshasb, Samaneh

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796

B

  1. Badawy, Mohamed

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  2. Bailey, Dale L.

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  3. Bailis, Nikolaos

    1. You have access
      Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
      Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230
  4. Baird, Grayson L.

    1. You have access
      Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
      Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711
  5. Barbato, Francesco

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  6. Barbet, Jacques

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  7. Barentsz, Jelle O.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  8. Barret, Olivier

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  9. Bauwens, Kevin

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  10. Bergsland, Emily K.

    1. Assessment and Comparison of <sup>18</sup>F-Fluorocholine PET and <sup>99m</sup>Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      You have access
      Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh and Thomas A. Hope
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1285-1291; DOI: https://doi.org/10.2967/jnumed.120.257303
  11. Bodar, Yves J.L.

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  12. Bodeker, Kellie L.

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  13. Bodet-Milin, Caroline

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  14. Boellaard, Ronald

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  15. Boers, Jorianne

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  16. Bohn, Karl Peter

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  17. Bonacorsi, Samuel J.

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  18. Booker, Kiara

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  19. Boonekamp, Michael

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  20. Bourgeois, Mickael

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  21. Brenner, Winfried

    1. You have access
      PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
      Winfried Brenner, Joachim Strobel and Vikas Prasad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1242-1243; DOI: https://doi.org/10.2967/jnumed.121.262737
  22. Brunsch, Celina L.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  23. Bushnell, David L.

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987

C

  1. Calais, Jeremie

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  2. Carlier, Thomas

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  3. Carrasquillo, Jorge A.

    1. You have access
      Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
  4. Carroll, Vincent M.

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  5. Cerato, Evelyne

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  6. Chan, David L.

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  7. Chen, Clara C.

    1. You have access
      Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
  8. Chen, Jianqing

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  9. Cheng, Jocelyn L.

    1. You have access
      Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
      Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711
  10. Chugani, Harry T.

    1. You have access
      Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
      Harry T. Chugani
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1301-1306; DOI: https://doi.org/10.2967/jnumed.120.256081
  11. Cohen, Daniel

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  12. Constantinescu, Cristian C.

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  13. Costa, Pedro Fragoso

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  14. Couturier, Olivier

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  15. Cysouw, Matthijs C.F.

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  16. Czernin, Johannes

    1. You have access
      Leadership Focus on Advancing Cancer Research and Treatment
      Johannes Czernin, Caius Radu and Antoni Ribas
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1178-1180; DOI: https://doi.org/10.2967/jnumed.121.262937
    2. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
    3. You have access
      The Annual Journal Impact Factor Saga
      Johannes Czernin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1177; DOI: https://doi.org/10.2967/jnumed.120.262860

D

  1. Dahlbom, Magnus

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  2. Dell’Oglio, Paolo

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  3. Denmeade, Samuel R.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  4. de Vries, Erik F.J.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  5. Dibble, Elizabeth H.

    1. You have access
      Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
      Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711
  6. Di Carli, Marcelo F.

    1. You have access
      Why Will PET Be the Future of Nuclear Cardiology?
      Marcelo F. Di Carli
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1189-1191; DOI: https://doi.org/10.2967/jnumed.120.254979
  7. Dijkstra, Lotte

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  8. Donnelly, David J.

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  9. Drui, Delphine

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  10. Dundar, Ayca

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048

E

  1. Eiring, Rachel A.

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  2. Eisenberger, Mario A.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  3. El-Haddad, Ghassan

    1. You have access
      Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Jonathan R. Strosberg, Taymeyah Al-Toubah and Ghassan El-Haddad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1321; DOI: https://doi.org/10.2967/jnumed.121.262340
  4. Elashoff, David

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931

F

  1. Faivre-Chauvet, Alain

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  2. Fendler, Wolfgang P.

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  3. Ferdinandus, Justin

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  4. Frampas, Eric

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791

G

  1. Gafita, Andrei

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  2. Gardner, Linda

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  3. Glaudemans, Andor W.J.M.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  4. Goldenberg, David M.

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  5. Gordon, Leonie L.

    1. You have access
      Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
      Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711
  6. Gorin, Michael A.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  7. Gosmann, Dario

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  8. Gotthardt, Martin

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  9. Gourni, Eleni

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  10. Graves, Stephen

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  11. Gray, David

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  12. Grogan, Tristan

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  13. Gunn, Roger N.

    1. Tau<sup>IQ</sup>: A Canonical Image Based Algorithm to Quantify Tau PET Scans
      You have access
      TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
      Alex Whittington, Roger N. Gunn and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1292-1300; DOI: https://doi.org/10.2967/jnumed.120.258962

H

  1. Halfdanarson, Thorvardur R.

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  2. Hayes, Wendy

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  3. Hendrikse, N. Harry

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  4. Herrmann, Ken

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  5. Hirmas, Nader

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  6. Hobday, Timothy J.

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  7. Hope, Thomas A.

    1. Assessment and Comparison of <sup>18</sup>F-Fluorocholine PET and <sup>99m</sup>Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      You have access
      Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh and Thomas A. Hope
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1285-1291; DOI: https://doi.org/10.2967/jnumed.120.257303
  8. Hospers, Geke A.P.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  9. Houghton, Jacob L.

    1. You have access
      Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
      Vilma I.J. Jallinoja and Jacob L. Houghton
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1200-1206; DOI: https://doi.org/10.2967/jnumed.120.260687
  10. Houwing, Krijn H.M.

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  11. Hyun, Hyewon

    1. You have access
      Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
      Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711

I

  1. Israël, Bas

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541

J

  1. Jallinoja, Vilma I.J.

    1. You have access
      Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
      Vilma I.J. Jallinoja and Jacob L. Houghton
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1200-1206; DOI: https://doi.org/10.2967/jnumed.120.260687
  2. Jansen, Bernard H.E.

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  3. Jha, Abhishek

    1. You have access
      Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
  4. Jochimsen, Thies H.

    1. You have access
      Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
      Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230

K

  1. Kendi, A. Tuba

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  2. Kirchner, Julian

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  3. Koene, Berend P.F.

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  4. Koza, Sylvia A.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  5. Krackhardt, Angela M.

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  6. Kraeber-Bodere, Francoise

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791

L

  1. Ladwa, Rahul

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  2. Lai, W. Victoria

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  3. Landgraf, Lisa

    1. You have access
      Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
      Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230
  4. Lange, Christian M.

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  5. Läppchen, Tilman

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  6. Lee, Chewah

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  7. Leung, David

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  8. Leyh, Catherine

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  9. Li, Bob T.

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  10. Lin, Frank I.

    1. You have access
      Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
  11. Lipovšek, Daša

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  12. Lira, Stephanie

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  13. Loudini, Naila

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826

M

  1. Madsen, Mark T.

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  2. Markowski, Mark C.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  3. Masrori, Pegah

    1. You have access
      Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
      Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere and Philip Van Damme
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1318-1319; DOI: https://doi.org/10.2967/jnumed.121.261942
  4. Masson, Damien

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  5. Mazzone, Elio

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  6. McCarthy, Timothy J.

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  7. Meijer, Dennie

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
  8. Melzer, Andreas

    1. You have access
      Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
      Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230
  9. Menda, Yusuf

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  10. Mingels, Clemens

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  11. Morin, Paul

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  12. Morley, Thomas

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008

N

  1. Nader, Michael

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  2. Nagarajah, James

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  3. Nguyen, Kathleen

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  4. Niklas-Hünermund, Jan

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741

O

  1. O’Dorisio, M. Sue

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  2. O’Dorisio, Thomas M.

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  3. Oprea-Lager, Daniela E.

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232

P

  1. Pacak, Karel

    1. You have access
      Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
  2. Packard, Annie T.

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  3. Papin, Caroline

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  4. Pattison, David

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  5. Pavlakis, Nick

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  6. Pienta, Kenneth J.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  7. Pomper, Martin G.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  8. Prasad, Vikas

    1. You have access
      PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
      Winfried Brenner, Joachim Strobel and Vikas Prasad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1242-1243; DOI: https://doi.org/10.2967/jnumed.121.262737
  9. Privé, Bastiaan M.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  10. Pryma, Daniel A.

    1. You have access
      Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697

R

  1. Radu, Caius

    1. You have access
      Leadership Focus on Advancing Cancer Research and Treatment
      Johannes Czernin, Caius Radu and Antoni Ribas
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1178-1180; DOI: https://doi.org/10.2967/jnumed.121.262937
  2. Rauscher, Aurore

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  3. Ribas, Antoni

    1. You have access
      Leadership Focus on Advancing Cancer Research and Treatment
      Johannes Czernin, Caius Radu and Antoni Ribas
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1178-1180; DOI: https://doi.org/10.2967/jnumed.121.262937
  4. Richter, Antonia

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  5. Rijpkema, Mark

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  6. Rischpler, Christoph

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  7. Roach, Paul J.

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  8. Robu, Stephanie

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  9. Rohmer, Vincent

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  10. Rominger, Axel

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  11. Roos, Paul R.

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  12. Rowe, Steven P.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226

S

  1. Sachpekidis, Christos

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  2. Sandiego, Christine

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  3. Schaarschmidt, Benedikt M.

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  4. Scheenen, Tom

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  5. Schilham, Melline G.M.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  6. Schröder, Carolina P.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      You have access
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
  7. Segall, George M.

    1. You have access
      ABNM Celebrating 50 Years
      George M. Segall
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 10N;
  8. Seibyl, John

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  9. Seidl, Christof

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  10. Sharkey, Robert M.

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
  11. Smith, Adam

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  12. Sraieb, Miriam

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  13. Steiger, Katja

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  14. Strobel, Joachim

    1. You have access
      PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
      Winfried Brenner, Joachim Strobel and Vikas Prasad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1242-1243; DOI: https://doi.org/10.2967/jnumed.121.262737
  15. Strosberg, Jonathan R.

    1. You have access
      Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Jonathan R. Strosberg, Taymeyah Al-Toubah and Ghassan El-Haddad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1321; DOI: https://doi.org/10.2967/jnumed.121.262340
  16. Suh, Insoo

    1. Assessment and Comparison of <sup>18</sup>F-Fluorocholine PET and <sup>99m</sup>Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      You have access
      Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh and Thomas A. Hope
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1285-1291; DOI: https://doi.org/10.2967/jnumed.120.257303
  17. Sullivan, Jenna M.

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008

T

  1. Tamagnan, Gilles

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  2. Thin, Pan

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
  3. Toulgoat, Frederique

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      You have access
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791

U

  1. Ulaner, Gary A.

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659
  2. Umutlu, Lale

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  3. Unger, Michael

    1. You have access
      Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
      Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230

V

  1. Van Damme, Philip

    1. You have access
      Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
      Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere and Philip Van Damme
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1318-1319; DOI: https://doi.org/10.2967/jnumed.121.261942
  2. Van Laere, Koen

    1. You have access
      Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
      Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere and Philip Van Damme
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1318-1319; DOI: https://doi.org/10.2967/jnumed.121.261942
  3. van Leeuwen, Fijs W.B.

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  4. van Leeuwen, Sven I.

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  5. van Oosterom, Matthias N.

    1. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      You have access
      Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
      Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
  6. Van Weehaeghe, Donatienne

    1. You have access
      Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
      Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere and Philip Van Damme
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1318-1319; DOI: https://doi.org/10.2967/jnumed.121.261942
  7. Velho, Pedro Isaacsson

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      You have access
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
  8. Villalobos, Anabella

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  9. Vis, André N.

    1. SUVs Are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      You have access
      SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
      Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232

W

  1. Wahl, Richard L.

    1. You have access
      Progress in Prostate Cancer Theranostics
      Richard L. Wahl
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 11N;
  2. Weber, Manuel

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  3. Weber, Wolfgang A.

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      You have access
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
  4. Wedemeyer, Heiner

    1. <sup>68</sup>Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      You have access
      68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
      Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
  5. Wee, Christopher E.

    1. You have access
      Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
  6. Whitman, Julia

    1. Assessment and Comparison of <sup>18</sup>F-Fluorocholine PET and <sup>99m</sup>Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      You have access
      Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
      Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh and Thomas A. Hope
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1285-1291; DOI: https://doi.org/10.2967/jnumed.120.257303
  7. Whittington, Alex

    1. Tau<sup>IQ</sup>: A Canonical Image Based Algorithm to Quantify Tau PET Scans
      You have access
      TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
      Alex Whittington, Roger N. Gunn and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1292-1300; DOI: https://doi.org/10.2967/jnumed.120.258962
  8. Wyld, David

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      You have access
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659

Z

  1. Zacho, Helle Damgaard

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      You have access
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
  2. Zamba, Gideon K.D.

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
  3. Zamecnik, Patrik

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
  4. Zhang, Lei

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      You have access
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
  5. Zhang, Xinrui

    1. You have access
      Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
      Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230
  6. Zhu, Shaojun

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      You have access
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (9)
Journal of Nuclear Medicine
Vol. 62, Issue 9
September 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
  • Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
  • Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
  • 68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire